Introduction
Migraine is a common multifactorial brain disorder with a prevalence of approximately 15% [
1,
2]. Migraine is typically characterized by recurrent attacks of severe, often unilateral pulsating headache accompanied by nausea, vomiting and/or photo- and phonophobia [
3]. Three times more women than men are affected. The sex difference is thought to be due to fluctuations in female sex hormones, as evidenced by observations that the prevalence of migraine strongly increases in women after menarche and attack frequency changes during pregnancy and menopause [
4]. One proposed mechanism is that a drop in the level of estrogen around menstruation would lead to increased brain excitability, thereby triggering the trigeminovascular system [
5,
6]. Activation of the trigeminovascular system involves firing of trigeminal (TG) neurons that innervate the meninges [
7‐
10]. We showed earlier that TG neurons express mechanosensitive Piezo1 channels that are activated by specific agonist Yoda1 [
11, 12]. In addition to Piezo1 channels, other nociceptors are likely involved in meningeal TG firing, such as non-mechanosensitive TRPV1 channels [
13]. Here we propose that mechanosensitive ‘transient receptor potential melastatin 3’ (TRPM3) channels, which were recently shown to be expressed in human sensory neurons [
14], are involved in the generation of migraine pain. Their functional role in nociception is apparent given that TRPM3 channels sense noxious heat and TRPM3 deficient mice show reduced inflammatory pain [
15]. Of relevance to migraine pathophysiology, TRPM3 channels co-localize in TG neurons with the nociceptive fibre neuropeptide calcitonin gene-related peptide (CGRP) [
16], of which plasma levels were shown to be elevated during migraine headache [
17] and antagonism of CGRP has proven effective in treating migraine [
18]. Most relevant to our study, TRPM3 channels respond to endogenous neurosteroid pregnenolone sulfate (PregS) [
19], and TRPM3 channel activation can be suppressed by sex hormones progesterone and 17β-oestradiol [
20]. Therefore, one can speculate that regulation of TRPM3 channels by sex hormones might, in fact, represent an endogenous inhibitory mechanism that modulates migraine attacks in females. Of note, the non-steroidal anti-inflammatory drug diclofenac and anticonvulsant primidone are highly efficient blockers of TRPM3 channels [
21]. Therefore, TRPM3 channels have been proposed as a clinically promising pharmacological target for analgesic strategies [
22], although this has not been considered yet for migraine. Here we show that TRPM3 channels are present in the meningeal part of the trigeminovascular system and can play a particular role in the generation of migraine pain in females.
Material and methods
Animals
Experiments were performed in 10- to 13-week-old male and female wildtype (WT) C57BL/6 J mice. Mice were bred in the Animal Facility of the University of Eastern Finland (UEF) and housed in special cages in rooms with controlled temperature 22 °C, humidity, and a 12-h light/dark cycle. Food and water were provided ad libitum. All experimental procedures were performed following the ethical guidelines of the European Community Council Directive of 22 September 2010 (2010/63/EEC). The study protocol was approved by the Animal Care and Committee of the University of Eastern Finland (licence EKS-008-2019, protocol from 25 November 2019). All measures were taken to minimize animal suffering in accordance with ARRIVE guidelines.
Hemiskull preparation and solutions
Isolated mouse hemiskull preparations for direct spike recordings from TG nerve endings were prepared as previously described [
13,
23]. In brief, after CO
2 inhalation and checking for lack of a pedal withdrawal reflex, mice were sacrificed by cervical dislocation followed by decapitation. Subsequent cleaning procedures were carried out for 15–20 min in oxygenated artificial cerebrospinal fluid (aCSF), containing (in mM): 120 NaCl, 2.5 KCl, 2 CaCl
2, 1 MgCl
2, 11 glucose, 24 NaHPO
4 and 30 NaHCO
3, bubbled with 95% O
2/5% CO
2 at room temperature (RT), while pH was maintained at 7.25–7.35. Skin and cranial muscles were removed from the outer side of the skull, which was then divided into two parts along the sagittal line using a scissors. To provide access for the recording electrode to the meningeal nerves branching out from the TG ganglia, the brain was gently removed with a forceps without harming the TG ganglia. Special attention was paid to keep the dura mater with meningeal nerves and vessels on the bone tissue inside the hemiskull (virtually) intact. After that, the isolated hemiskull was placed in a recording chamber continuously perfused with aCSF (6–7 mL/min) and oxygenated with 95% O
2/5% CO
2 mixture.
Drugs were purchased from Tocris Bioscience, UK, i.e. TRPM3 channel agonists pregnenolone sulfate (PregS) and CIM0216, Piezo1 agonist Yoda1 and transient receptor potential vanilloid 1 (TRPV1) channel agonist capsaicin and dissolved in DMSO. Substances were diluted to a final concentration in aCSF immediately before usage and applied to the receptive field around the main meningeal branch of the TG nerve by fast perfusion (~ 6 mL/min).
Electrophysiological recordings
To detect TRPM3 mechanosensitive channels in TG nerves of meningeal tissue, we employed direct electrophysiological spike recording of nociceptive firing from peripheral meningeal nerve terminals. In the preparation stage, after placing the hemiskull preparation into the recording chamber, the main meningeal branch of the TG nerve was cleaned from surrounding tissue and cut at a distance of ~ 0.5 mm from the TG ganglion. Next, a small incision was made in the dura mater, and the peripheral part of the cut meningeal branch was placed into a recording glass microelectrode filled with aCSF. The exposed tip of the microelectrode was adjusted to the nerve diameter to allow the nerve ending to entirely plug it. Next, a silver reference electrode was placed into the bath containing the hemiskull preparation. At the start of each experiment, to allow the nerve to be tightly sucked into the electrode and stabilize the baseline, 10 min of spontaneous spike activity was recorded as control. After baseline recording, 50 mM KCl with compensated osmolarity was applied to verify the neuronal activity of the preparation. Next, to demonstrate the presence of mechanosensitive fibres, mechanosensitive Piezo1 channels [
12] were activated with Yoda 1 (5 μM) whereas TRPM3 mechanosensitive channels were activated with PregS (50 μM) or CIM0216 (5 μM). Finally, as a marker of non-mechanosensitive nociceptive neuronal activity mediated by TRPV1 receptors, capsaicin (1 μM) was applied. Note that all drug applications were made to the same peripheral terminal of the meningeal nerve and lasted for 10 min with subsequent perfusion for 20 min (washout). Because Yoda1, PregS, CIM0216 and capsaicin were all prepared in DMSO, a pre-application of vehicle solution containing the same concentration of DMSO was administered, which did not significantly affect spiking activity of the TG nerve.
Electrophysiological recordings of neuronal spiking activity generated in the peripheral part of the meningeal nerves were registered at RT using a low-noise digital amplifier (ISO-80; World Precision Instruments, Sarasota, FL, USA) with the following parameters: gain 10,000X and bandpass 300–3000 Hz. Obtained electrical signals were digitized at 8-μsec intervals using a NIPCI 6221 data acquisition board (National Instruments, Austin, TX, USA) and stored on a PC for offline analysis. Signals were visualized by WinEDR v.3.5.2 software (University of Strathclyde, Glasgow, UK) and analyzed with MATLAB-based software (MathWorks, Natick, MA, USA) [
13].
Cluster and spectral analysis of spiking activity
Advanced cluster and spectral spike analysis was performed, as described previously [
13,
24,
25]. In brief, before analysis, all original recordings were filtered at 100–9000 Hz using a Chebyshev type 2 filter for spike detection and subsequent cluster and spectral analysis. The baseline noise level was estimated at the beginning of each experiment in a spikeless interval lasting at least 20 s to determine the respective threshold for spike detection. A recording was considered to contain spikes when the potential amplitude exceeded 5 standard deviations (SD) of the level of baseline noise. Spike amplitudes were normalized by baseline noise and expressed as SD values (arbitrary units, a.u.). Two-phase signals with a duration in the range of 0.3–1.8 ms were considered to represent action potentials, for which the spike rate was presented as number of spikes per 10 s. Using MATLAB software, for each spike, we calculated parameters such as the rise and decay time, the amplitude of positive and negative phases, spike areas, and their total duration. The ‘KlustaKwik’ application [
26] was used to automatically recognize the most compact groups of spikes (clusters). Amplitudes of positive and negative phases of spikes were used as input parameters for clusterization. This approach allowed us to separate the total flow of spikes into 7 to 30 individual clusters for each experiment. For spectral analysis, data were analyzed with respect to the number of interspike intervals (ISI) per second, both for the whole nerve and for spike activity of individual clusters.
Data analysis and statistics
Electrophysiological data were analyzed and plotted using Origin Pro (Origin Lab Corporation, Northampton, MA, USA) and Graph Pad Prizm (GraphPad Prizm Software, La Jolla, CA, USA). We used at least five independent replicates for each set of experiments, where n corresponds to the number of animals. The resulting data were presented as the mean ± standard error of the mean (m ± SEM). The significance level was set at p < 0.05, statistically assessed by the Wilcoxon signed-rank test for paired data and the Mann–Whitney U test for unpaired data.
Discussion
One of the main findings of our study is the demonstration of functional TRPM3 channels in peripheral meningeal terminals of the TG nerve. In addition, we could show that the spiking activity at terminals in response to activation of TRPM3 channels was higher in females than in males. Hence, we provided first experimental evidence of the presence and function of TRPM3 channels in nerves that are considered very relevant for migraine pathogenesis. Moreover, our spike cluster analysis revealed the diverse contribution of individual TG fibres to nociceptive firing induced by TRPM3 channel activation, with preferential induction of large-amplitude spikes in female mice. Spectral analysis also showed a difference between both sexes with respect to the prevailing spiking activity of nociceptive firing evoked by the CIM0216, namely θ- and α-ranges of spiking activity in females and δ- and θ-ranges in males. Taken together, our study suggests that activation of TRPM3 channels may be involved in triggering pain generation in meninges and seems to play a prominent role in mechanisms underlying sex differences in migraine pathology.
There is compelling evidence that activation of the meningeal trigeminovascular system through firing of peripheral nerve terminals is involved in initiating migraine headaches [
13,
29]. Many molecules and signalling pathways are likely involved in detecting, transduction, and propagation of this nociceptive firing [
30,
31]. One of the less-studied but interesting molecular sensors is the TRPM3 channel with its wide hormonal regulation profile and recently proposed role in nociceptive mechanisms [
32]. In addition, TRPM3 channels are expressed in the peripheral nervous system, where they have been characterized as a noxious heat sensor in somatosensory neurons [
15,
33,
34]. Although TRPM3 channels have been intensively studied in somatosensory neurons of DRGs and TG ganglia [
15], they have not been considered as relevant to migraine pathophysiology and had not been identified in the meningeal afferents. Considering the rising spiking activity in meningeal afferents as a nociceptive effect [
13,
35], we here provide first evidence of TRPM3 channels in relation to the site of origin of migraine pain.
Although we used PregS at a high micromolar concentration to obtain a robust activation of TG nerve terminals, there is already noticeable activation of TRPM3 channels in the somatosensory system at low nanomolar (physiological) concentrations [
15]. This may suggest that PregS can sensitise nociceptive afferents for other potential triggers or trigger migraine-related nociceptive firing in meningeal afferents in conditions when the concentration of the endogenous steroid is increased, e.g. during parturition and under various pathological conditions [
36]. Further support for the role of TRPM3 in meningeal nociception was obtained in our present study that revealed an exceptionally strong sex-dependent effect of synthetic agonist CIM0216 on the activation of TG fibres. It is worth mentioning, that PregS activated the TRPM3 channels during the entire 10 min of application, whereas 5 μM CIM0216 induced only a short-lasting activation followed by a block of all nociceptive activity. This silencing of firing after activation could be either due to desensitization of TRPM3 receptors as desensitization is a common agonist-specific mechanism shaping the duration of physiological responses or activation of calcium-dependent potassium conductance, which limits the depolarizing response in primary afferents. The latter obviously is stronger in the case of CIM0216, which triggers, more so than PregS, calcium influx via TRPM3 channels.
To disentangle nociceptive signalling caused by PregS in TG fibres, we used cluster analysis that can identify clusters (fibres) that simultaneously, but selectively, respond to more than one agonist or just one agonist. Our comparative analysis showed that the profile of ‘only-PregS-sensitive’ and ‘capsaicin-sensitive fibres’ did not reveal sex-dependence. Moreover, in both sexes, we found that activation of TRPM3 channels by PregS reveals clusters that had been silent before drug application. However, unlike in males, in females such clusters showed a massive and repetitive escalation of spike frequency in meningeal afferents. Furthermore, the ‘woken-up’ spike clusters consist of a larger amplitude and a faster time-course, which is a typical signature of Aδ fibres [
28]. It is also worth mentioning that females and males differed with respect to the group of clusters that responded to both Yoda1 and PregS (23% vs. 7%), which reflects sex differences in the co-existence of the two types of mechanosensitive channels Piezo1 and TRPM3. In addition, cluster analysis indicated that, in females, the number of ‘super-mechanosensitive’ fibres (i.e. those expressing both TRPM3 and Piezo1 channels) was two times higher than in males. Taken together, the data reveal that, unlike Piezo1 and TRPV1 channels, the contribution of TRPM3 channels to nociception firing is different between sexes at the level of single fibres in meningeal afferents.
Mechanosensitive channels can be activated by a variety of mechanical or chemical stimuli [
37], so it remains an enigma which of the stimuli play a role in the activation of meningeal afferents. There are several potential factors converting mechanical stimuli into electrical signals, such as osmotic swelling (proposed for TRPM3 channels [
38]) and pulsatile blood flow in the meninges (proposed for Piezo1 channels [
11]). Mechanically sensitive Piezo1 channels were recently identified in peripheral meningeal terminals of TG ganglia [
11,
12]. However, data presented in the current study, for the first time, show the absence of a sex difference in the activation of Piezo1 channels in meningeal afferents that have been implicated in the pathogenesis of migraine headache.
The revealed absence of sex differences in the nociceptive responses to Piezo1 agonist Yoda1 or TRPV1 agonist capsaicin underscores the specific role of sex in the regulation of TRPM3 channels. Unlike Piezo1 channels, which can be activated by synthetic agonist Yoda1, TRPM3 channels in the case if they are activated by the endogenous agonist PregS, potentially could be suppressed by sex hormones progesterone and 17β-oestradiol [
20]. In comparison with DHT, progesterone is more powerful and shows effects with EC50 in the range from 10 nM to 10 μM with retention of its impact in the absence of PregS. In their study, Majeed and co-authors stated that 17β-estradiol had much less or no inhibitory effect on TRPM3 channel activity. In clinical studies, effects of progesterone on TRPM3 channels were observed at the upper end of the physiologically relevant concentration range, with an EC50 of 1–2 nM, rising to 30–50 nM in the luteal phase of the menstrual cycle [
39]. This increases the likelihood that TRPM3 channels are regulated by progesterone in vivo. Of note, it was also shown that 17β-estradiol increased neurogenic vasodilation in the dura mater, suggesting an increased release of CGRP from the perivascular nerves. This may be one mechanism by which 17β-estradiol exacerbates migraines in women [
40]. Of relevance, it was shown that expression of the TRPM3 channel gene
Trpm3 increased during proestrus in mice, precisely when estrogen and progesterone levels change, i.e. estradiol rises within 12 h and peaks at about midday, and then, over the next 6 h drops to one fifth of the peak level [
41]. The dramatic decrease in estradiol during proestrus co-incides with an increase in progesterone [
42‐
44]. The intriguing role of female hormones in modulating the activity of TRPM3 channels deserves further exploration in in vivo models of migraine.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.